Nature Search

Correction: Corrigendum: Src activation by β-adrenoreceptors is a key switch for tumour metastasis

Guillermo N. Armaiz-Pena
Julie K. Allen
Anil K. Sood
Amendments and Corrections29 Jul 2013
Nature Communications

Volume: 4, P: 1
Author Correction: Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression

Rajesha Rupaimoole
Sherry Y. Wu
Anil K. Sood
Amendments and Corrections03 Jun 2020
Nature Communications

Volume: 11, P: 1-2
A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer

The formation of blood vessels in tumours, angiogenesis, is a promising target for therapy. Here, the authors show that microRNA192 has anti-angiogenic functions and negatively regulates EGR1 and HOXB9, and that delivery of this microRNA to tumours in vivocan reduce angiogenesis and tumour growth.

Sherry Y. Wu
Rajesha Rupaimoole
Anil K. Sood
ResearchOpen Access04 Apr 2016
Nature Communications

Volume: 7, P: 1-14
2′-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity

Short interfering siRNAs—siRNAs—have therapeutic potential in the treatment of disease; however, their delivery to target tissues is difficult. Here, Wu et al. chemically modify siRNAs and show that this improves loading into the siRNA silencing machinery and thus efficacy in eliminating cancer cells in mice.

Sherry Y. Wu
Xianbin Yang
Anil K. Sood
Research12 Mar 2014
Nature Communications

Volume: 5, P: 1-12
Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression

MicroRNAs play important roles in the maintenance of cellular homeostasis through the post-transcriptional regulation of gene expression. Here, the authors implicate loss of the miRNA biogenesis factor Drosha and altered miRNA maturation in tumour progression under hypoxic conditions.

Rajesha Rupaimoole
Sherry Y. Wu
Anil K. Sood
Research29 Oct 2014
Nature Communications

Volume: 5, P: 1-13
Src activation by β-adrenoreceptors is a key switch for tumour metastasis

The neurotransmitter noradrenaline can regulate cellular processes that contribute to cancer progression, but the underlying mechanisms remain largely unknown. Here the authors identify Src as a key mediator of noradrenaline signalling networks in tumour metastasis.

Guillermo N. Armaiz-Pena
Julie K. Allen
Anil K. Sood
Research29 Jan 2013
Nature Communications

Volume: 4, P: 1-12
FABP4 as a key determinant of metastatic potential of ovarian cancer

In ovarian cancer, metastatic phenotype may impact surgical outcomes. Here, the authors show miR-409-3p regulates FABP4 which can increase metastatic potential of ovarian cancer, and treatment with DOPC nanoliposomes containing either miR-409--3p mimic or FABP4 siRNA inhibits tumor progression in mice.

Kshipra M. Gharpure
Sunila Pradeep
Anil K. Sood
ResearchOpen Access26 Jul 2018
Nature Communications

Volume: 9, P: 1-14
Platelets reduce anoikis and promote metastasis by activating YAP1 signaling

Platelets have been associated with increased tumor growth and metastasis but the mechanistic details of this interaction are still unclear. Here the authors show that platelets improve anoikis resistance of cancer cells and increase metastasis by activating Yap through a RhoA/MYPT-PP1 pathway.

Monika Haemmerle
Morgan L. Taylor
Anil K. Sood
ResearchOpen Access21 Aug 2017
Nature Communications

Volume: 8, P: 1-15

Search

Filter By:

Search

Quick links